Orla McArdle

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

Hisham Mehanna, Max Robinson, A. Hartley et al. · The Lancet · 2018 · 988 citations · Full text

Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study

Alina Sturdza, Richard Pötter, Lars Fokdal et al. · Radiotherapy and Oncology · 2016 · 680 citations

Advanced Cervical Cancer, Cervical Cancer, Radiation Therapy +11

A cardiac contouring atlas for radiotherapy

Frances Duane, Marianne Aznar, Freddie Bartlett et al. · Radiotherapy and Oncology · 2017 · 288 citations · Full text

Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study

Boon Chua, Emma Link, Ian Kunkler et al. · The Lancet · 2022 · 102 citations · Full text

Radiation Medicine, Breast Oncology, Radiation Therapy +11

Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial

Madeleine King, Emma Link, Timothy J. Whelan et al. · The Lancet Oncology · 2020 · 49 citations

Surgical Oncology, Breast Oncology, Health Sciences +10